Therefore, probiotics show great potential and value in the management of IBD by precisely regulating key inflammatory pathways such as NF-κB, reshaping disordered intestinal flora (especially correcting the imbalance of F/B ratio) and strengthening the intestinal barrier (Figure 2). The gene discussed is NFKB1; the disease is inflammatory bowel disease.